Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
Go back to Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control| (NASDAQ: CRNX) | Delayed: 83.65 -0.07 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.72 | 52 Week High | $ | |||
| Open | $83.78 | 52 Week Low | $ | |||
| Day High | $83.79 | P/E | N/A | |||
| Day Low | $83.64 | EPS | $ | |||
| Volume | 4,268,877 | |||||

